Neurology News

Researchers recently found that the pharmacokinetic properties of vesicular monoamine transporter 2 inhibitors may play a role in the treatment of tardive dyskinesia.

Marriage was associated with a lower risk for dementia and mild cognitive impairment in later life, researchers reported in the Journal of Aging and Health.

Aculys Pharma, Inc. announced the initiation of a phase 3 trial of pitolisant, a histamine H3 receptor antagonist/inverse agonist in those with excessive daytime sleepiness that is associated with obstructive sleep apnea syndrome.

An analysis of hundreds of stroke trials shows significantly more men than women were registered as principal investigators from 2011 to 2020, with the most striking difference observed for acute stroke trials, researchers reported.

In a cohort of patients who had transcatheter aortic valve replacement at 22 hospitals in Michigan, post-TAVR stroke was more common at institutions designated as comprehensive stroke centers, researchers reported.

The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release.

A record number of Americans — 16.3 million — signed up for health insurance through Affordable Care Act Marketplaces in 2023, the Biden-Harris administration announced Wednesday.

Reduced kidney function was associated with increased levels of dementia-related blood biomarkers, but not an increased risk for Alzheimer’s disease or dementia, researchers reported in JAMA Network Open.

Amazon has further expanded its reach into health care with a new discount prescription drug program.

A web-based system for the diagnosis and treatment of recurrent benign paroxysmal positional vertigo was shown to be effective, researchers reported in JAMA Neurology.